The discovery and development of biologics is complex, time-consuming and expensive because they’re derived from living organisms. A new drug discovery company based in Madison, Wis. called Invenra Inc. says it has a platform that could overcome some of the barriers that limit the discovery of new biologic drugs in areas like cancer, Alzheimer’s disease and diabetes. The company disclosed in a securities filing that it has raised $3 million. Read the full MedCity News story here.